Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy

about

Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy

Item

http://www.wikidata.org/entity/Q58101662

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@en

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@nl

type

Item

label

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@en

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@nl

prefLabel

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@en

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@nl

P1476

Diffusion-weighted MR imaging ...... se to neoadjuvant chemotherapy

@en

P2093

Bing-Quan Lin

http://www.w3.org/2001/XMLSchema#string

Chang-Qing Li

http://www.w3.org/2001/XMLSchema#string

Cheng-Gong Yan

http://www.w3.org/2001/XMLSchema#string

Jian-Jun Li

http://www.w3.org/2001/XMLSchema#string

Li Yuan

http://www.w3.org/2001/XMLSchema#string

Peng Hao

http://www.w3.org/2001/XMLSchema#string

Yi-Kai Xu

http://www.w3.org/2001/XMLSchema#string

Yuan-Kui Wu

http://www.w3.org/2001/XMLSchema#string

Ze-Long Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations

Statistical methods for assessing agreement between two methods of clinical measurement

IVIM Diffusion-weighted Imaging of the Liver at 3.0T: Comparison with 1.5T.

Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.

Time-window of early detection of response to concurrent chemoradiation in cervical cancer by using diffusion-weighted MR imaging: a pilot study.

DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin.

Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.

Magnetic resonance imaging of breast lesions--a pathologic correlation.

P2888

s40644-018-0173-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40644-018-0173-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107916794

http://www.w3.org/2001/XMLSchema#string

P698

30373679

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6206724

http://www.w3.org/2001/XMLSchema#string